Association between opium use and metabolic syndrome among an urban population in Southern Iran: Results of the Kerman Coronary Artery Disease Risk Factor Study (KERCADRS)
Publish place: ARYA Atherosclerosis، Vol: 11، Issue: 1
Publish Year: 1394
نوع سند: مقاله ژورنالی
زبان: English
View: 105
This Paper With 7 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_RYA-11-1_003
تاریخ نمایه سازی: 2 شهریور 1401
Abstract:
BACKGROUND: Along with the established effects of opium on metabolic parameters, stimulatory or inhibitory effects of opium on metabolic syndrome are also predictable. This study aimed to examine the association of opium use with metabolic syndrome and its components. METHODS: This study was conducted on ۵۳۳۲ out of ۵۹۰۰ original sample participants enrolled in a population-based cohort entitled the Kerman Coronary Artery Disease Risk Study in Iran from ۲۰۰۹ to ۲۰۱۱. The subjects were divided into three groups of “non-opium users” (NOUs = ۴۳۴۰ subjects), “former opium users” (FOUs = ۱۷۶ subjects), and dependent and occasional people named “current opium users” (COUs = ۸۱۱ subjects). Metabolic syndrome was defined according to two International Diabetes Federation (IDF) and National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) definition criteria. RESULTS: The overall prevalence of IDF defined-metabolic syndrome among NOUs, FOUs, and COUs was ۳۶.۴%, ۲۷.۳%, and ۳۹.۰%, respectively; which was significantly higher in the COUs group (P = ۰.۰۱۲). However, no significant difference was revealed across the three groups in prevalence of NCEP defined-metabolic syndrome (NOUs = ۳۷.۲%, FOUs = ۳۰.۱%, and COUs = ۳۹.۶%, P = ۰.۰۵۸). The odds for IDF defined-metabolic syndrome was higher in both COUs [odd ratio (OR) = ۱.۲۸, P = ۰.۰۲۸)] and FOUs (OR = ۱.۵۷, P = ۰.۰۴۵) compared with NOUs as the reference adjusting gender, age, body mass index, and cigarette smoking. However, the appearance of NCEP defined-metabolic syndrome could not be predicted by opium use. CONCLUSION: Opium use can be associated with an increased risk for metabolic syndrome based on IDF criteria and thus preventing the appearance of metabolic syndrome by avoiding opium use can be a certain approach to preventing cardiovascular disease.
Keywords:
Authors
Gholamreza Yousefzadeh
Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
Mostafa Shokoohi
Research Center for Modeling in Health, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
Hamid Najafipour
Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
Mahmood Eslami
Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
Farank Salehi
Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran